SeekingAlpha  Sep 29  Comment 
By Andy Batts: Thoratec (NASDAQ:THOR) announced that D. Keith Grossman has been appointed president and chief executive officer, effective immediately. Mr. Grossman succeeds Gary F. Burbach, who has stepped down from his CEO and board positions....
StreetInsider.com  Sep 22  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Thoratec%27s+%28THOR%29+New+CEO+Seen+as+Positive%2C+Says+Wells+Fargo+%28Earlier%29/9851088.html for the full story.
StreetInsider.com  Sep 22  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Thoratec+%28THOR%29+Appoints+New+CEO%3B+Prelim.+Q3+Revs+Miss+Views/9849231.html for the full story.
Benzinga  Sep 22  Comment 
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that D. Keith Grossman has been appointed President and Chief Executive...
StreetInsider.com  Sep 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Thoratec+%28THOR%29+Begins+Heartmate+III+U.S.+Clinical+Trial/9818990.html for the full story.
Market Intelligence Center  Sep 9  Comment 
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with Thoratec (THOR) that should provide a 7.05% return in just 130 days. Sell one Jan. '15 call at the $24.00 level for each 100 shares of...
StreetInsider.com  Aug 25  Comment 
UPGRADES Credit Suisse upgrades US Steel (NYSE: X) from Underperform to Outperform with a price target of $50. Howard Weil moves WPX Energy (NYSE: WPX) from Sector Perform to Outperform with a price target of $32. Raymond James boosts CBOE...
Benzinga  Aug 25  Comment 
Analysts at Piper Jaffray downgraded Thoratec (NASDAQ: THOR) from Overweight to Neutral. The target price for Thoratec has been lowered from $40 to $27. Thoratec shares have dropped 33.19% over the past 52 weeks, while the S&P 500 index has...
Benzinga  Aug 25  Comment 
SeekingAlpha  Aug 19  Comment 
By KL Investment Partners: Sources (unless stated otherwise): Investor presentation (click here), 2Q2014 earnings call (click here), and 10-K (click here). Thoratec Corporation (NASDAQ:THOR) is a world leader in the development, manufacture and...
SeekingAlpha  Aug 14  Comment 
By Andy Batts: Heart-device maker Thoratec (NASDAQ:THOR) reported weak financial results for the second quarter of 2014. Revenues in the second quarter came in at $118.1 million, a 10% decrease compared to revenues of $130.5 million in the same...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki